HPV Educational Intervention to Increase Acceptance and Completion of Free HPV Vaccination Among Underserved Adults

Last updated: August 8, 2025
Sponsor: Mayo Clinic
Overall Status: Active - Not Recruiting

Phase

4

Condition

Human Papilloma Virus (Hpv)

Gynecological Infections

Treatment

Educational Intervention

Survey Administration

Clinical Study ID

NCT04474821
18-010455
18-010455
NCI-2020-04723
  • Ages 18-45
  • All Genders

Study Summary

This phase IV trial examines the impact of an education program on the human papilloma virus (HPV) and its effects on the acceptance and completion rates of a free HPV vaccination program in underserved adult patients. Participating in the HPV educational program may increase the HPV vaccination rates among low income uninsured adult patients and ultimately prevent HPV related cancers.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Male and female adults patients seen at Volunteers in Medicine ages 18-45 years ofage who read and understand English or Spanish

Exclusion

Exclusion Criteria:

  • Children (under 18 years of age)

  • Individuals who had previously received any dose of HPV vaccine

Study Design

Total Participants: 100
Treatment Group(s): 2
Primary Treatment: Educational Intervention
Phase: 4
Study Start date:
October 19, 2020
Estimated Completion Date:
December 22, 2025

Study Description

PRIMARY OBJECTIVES:

I. Determine the acceptability and completion rates of free HPV vaccination among the underserved adult patients at the Volunteer in Medicine Clinic (VIM) in Jacksonville, Florida.

II. Determine if an education program on HPV vaccination increases the acceptability of free HPV vaccination among the underserved adult patients at the Volunteer in Medicine Clinic (VIM) in Jacksonville, Florida.

III. Determine the baseline prevalence of HPV vaccination completion rates among VIM patients age 18-45.

IV. Determine if there are differences in acceptance and completion rates of HPV vaccination, among VIM patients of different sex, age (18-26 versus [vs] 27-45), ethnicity or race, following an education program on HPV as part of this protocol participation.

VI. Assessing possible barriers for vaccine series completion. VII. Determine if follow up intervention increases completion rate of free HPV vaccine series within 9 months.

OUTLINE:

Patients receive educational materials on HPV and are asked of their willingness to proceed with the first HPV vaccination. Patients who express interest in receiving the HPV vaccination, then receive the first dose of the HPV vaccine and the next 2 doses approximately 2 months and 6 months following the initial vaccine.

Connect with a study center

  • Mayo Clinic in Florida

    Jacksonville, Florida 32224-9980
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.